Oncopeptides AB (publ) (LON: 0RN4)
London
· Delayed Price · Currency is GBP · Price in SEK
1.344
-0.018 (-1.32%)
At close: Jan 21, 2025
Oncopeptides AB Market Cap
Oncopeptides AB has a market cap or net worth of 21.22 million as of January 23, 2025. Its market cap has decreased by -62.04% in one year.
Market Cap
21.22M
Enterprise Value
11.43M
Revenue
1.99M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.34
Market Cap Chart
Since February 22, 2017, Oncopeptides AB's market cap has decreased from 149.07M to 21.22M, a decrease of -85.76%. That is a compound annual growth rate of -21.82%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 171.37B |
Shell | 167.06B |
HSBC Holdings | 144.71B |
Unilever | 113.14B |
Rio Tinto Group | 85.64B |
RELX PLC | 74.07B |
BP p.l.c. | 67.25B |
British American Tobacco p.l.c. | 65.03B |